Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONGeneric

NEBUPENT

PENTAMIDINE ISETHIONATE

Standard Dose
600MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NEBUPENT is listed in Drugs@FDA under application 019887 (NDA).

Marketing status: Discontinued Active ingredient PENTAMIDINE ISETHIONATE Form and strength FOR SOLUTION;INHALATION - 600MG/VIAL Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2013-02-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview NEBUPENT is listed in Drugs@FDA under application 019887 (NDA). Marketing status: Discontinued Active ingredient PENTAMIDINE ISETHIONATE Form and strength FOR SOLUTION;INHALATION - 600MG/VIAL Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2013-02-16 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.